8/21/2019 9:11:18 PM
Avinger Prices $4.5 Mln Underwritten Public Offering Of Common Stock
4/10/2019 8:15:19 AM
Avinger Receives FDA Clearance Of Pantheris SV Device
3/6/2019 4:14:00 PM
Avinger Q4 Loss/share $0.31 Vs. Loss $12.58 Year Ago
12/19/2018 6:02:20 AM
Avinger Announces Release Of Preliminary Analysis Of Results From Its SCAN Clinical Study
8/30/2018 8:32:50 AM
Avinger Submits New 510(k) Application To FDA For Pantheris SV Lumivascular Atherectomy System
8/23/2018 8:35:00 AM
Avinger Completes Enrollment In SCAN Clinical Study
7/12/2018 8:34:56 AM
Avinger Announces Pricing Of $3.55 Mln Registered Direct Offering
7/10/2018 8:32:13 AM
Avinger Appoints Jaafer Golzar As Chief Medical Officer
6/14/2018 8:31:33 AM
Avinger Says First Patients Enrolled In Post-Market Study Comparing Pantheris OCT Imaging To Intravascular Ultrasound